The frontostriatal circuitry and behavioral complications in PD

Parkinsonism and Related Disorders

Volumn 18, Issue SUPPL. 1, 2012, Pages

  Tang, Joyce ^a   Strafella, Antonio P ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Frontostriatal circuitry; Imaging; Impulse control disorders; Mood disorders; Parkinson's disease; Pet; Reward

Indexed keywords

CITALOPRAM; DOPAMINE; LEVODOPA; NORTRIPTYLINE; PAROXETINE; PRAMIPEXOLE; SEROTONIN; DOPAMINE RECEPTOR STIMULATING AGENT;

APATHY; ARTICLE; BRAIN DEPTH STIMULATION; BRAIN REGION; CLINICAL FEATURE; CORPUS STRIATUM; DEPRESSION; DISEASE ASSOCIATION; FRONTAL CORTEX; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; IMPULSE CONTROL DISORDER; MOOD DISORDER; NERVE CELL NETWORK; NEUROCHEMISTRY; NEUROIMAGING; NEUROMODULATION; NEUROPATHOLOGY; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; SUBTHALAMIC NUCLEUS; BASAL GANGLION; BRAIN CORTEX; FRONTAL LOBE; QUALITY OF LIFE; THALAMUS;

EID: 84858683931     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/s1353-8020(11)70033-5     Document Type: Article

References (20)

1. Braak H, Ghebremedhin E, Rüb U, Bratzke H, Del Tredici K. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 2004;318(1):121-34.
2. Antonelli F, Ray N, Strafella AP. Imaging cognitive and behavioral symptoms in Parkinson's disease. Expert Rev Neurother 2010;10(12):1827-38.
3. Kano O, Ikeda K, Cridebring D, Takazawa T, Yoshii Y, Iwasaki Y. Neurobiology of depression and anxiety in Parkinson's disease. Parkinsons Dis 2011;143547.
4. Assogna F, Cravello L, Caltagirone C, Spalletta G. Anhedonia in Parkinson's disease: A systematic review of the literature. Mov Disord 2011 [Epub ahead of print]. doi: 10.1002/mds.23815.
5. Aarsland D, Marsh L, Schrag A. Neuropsychiatric symptoms in Parkinson's disease. Mov Disord 2009;24(15):2175-86.
6. Brooks DJ, Pavese N. Imaging non-motor aspects of Parkinson's disease. Prog Brain Res 2010;184:205-18.
7. Strecker K, Wegner F, Hesse S, Becker GA, Patt M, Meyer PM, Lobsien D, Schwarz J, Sabri O. Preserved serotonin transporter binding in de novo Parkinson's disease: negative correlation with the dopamine transporter. J Neurol 2011;258(1):19-26.
8. Volkmann J, Daniels C, Witt K. Neuropsychiatric effects of subthalamicneurostimulation in Parkinson disease. Nat Rev Neurol 2010;6(9):487-98.
9. Black KJ, Hershey T, Hartlein JM, Carl JL, Perlmutter JS. Levodopa challenge neuroimaging of levodopa-related mood fluctuations in Parkinson's disease. Neuropsychopharmacology 2005;30(3):590-601.
10. Tinaz S, Courtney MG, Stern CE. Focal cortical and subcortical atrophy in early Parkinson's disease. MovDisord 2011;26(3):436-41.
11. Matsui H, Nishinaka K, Oda M, Niikawa H, Komatsu K, Kubori T, Udaka F. Depression in Parkinson's disease. Diffusion tensor imaging study. J Neurol 2007;254(9):1170-3.
12. Chaudhuri KR, Schapira AH. Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. Lancet Neurol 2009;8(5): 464-74.
13. Ray N, Strafella AP. Dopamine, reward, and frontostriatal circuitry in impulse control disorders in Parkinson's disease: insights from functional imaging. Clin EEG Neurosci 2010;41(2):87-93.
14. Frank MJ, Samanta J, Moustafa AA, Sherman SJ. Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism. Science 2007; 318(5854):1309-12.
15. van Eimeren T, Pellecchia G, Cilia R, Ballanger B, Steeves TD, Houle S, Miyasaki JM, Zurowski M, Lang AE, Strafella AP. Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD. Neurology 2010;75(19):1711-6.
16. Steeves TD, Miyasaki J, Zurowski M, Lang AE, Pellecchia G, Van Eimeren T, Rusjan P, Houle S, Strafella AP. Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain 2009;132:1376-85.
17. Ray N, Antonelli F, Strafella AP. Imaging impulsivity in Parkinson's disease and the contribution of the subthalamic nucleus. Parkinsons Dis 2011:594860.
18. Rodriguez-Oroz MC, López-Azcárate J, Garcia-Garcia D, Alegre M, Toledo J, Valencia M, Guridi J, Artieda J, Obeso JA. Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease. Brain 2011;134:36-49.
19. Wiecki TV, Frank MJ. Neurocomputational models of motor and cognitive deficits in Parkinson's disease. Prog Brain Res 2010;183:275-97.
20. Ballanger B, van Eimeren T, Moro E, Lozano AM, Hamani C, Boulinguez P, Pellecchia G, Houle S, Poon YY, Lang AE, Strafella AP. Stimulation of the subthalamic nucleus and impulsivity: release your horses. Ann Neurol 2009;66(6):817-24.